Health and Human Services Secretary Robert F. Kennedy Jr. has appointed eight new members to the Advisory Committee for Immunization Practices two days after firing all 17 members. Kennedy named the new members in a post on X on Wednesday.
The American Medical Association on Wednesday said it strongly supports the Medicare Patient Access and Practice Stabilization Act of 2025 that would temporarily reverse the 2.83% payment cut to physicians.
Julie Johnson, a nurse at the University of Chicago, was recruited to translate clinical ideas into data, which is then delivered back in a way that medical staff know how to approach analyzing it.
Cigna is introducing an AI-powered virtual assistant to help members get their questions answered during health insurance interactions.
Twelve teams participated in the competition held by Cooper University Health Care – which has in its inner-city DNA an awareness of SDOH issues such as exposure to violence, access to healthy food and stable housing – to create care in communities, says Chief Innovation Officer Dr. Michael Kirchhoff.
WiTT Group, which stands for “We’re in This Together,” offers an online registry to help cancer patients with the SDOH needs that delay treatment, says founder and cancer patient Rahul Mahadevan.
Healthcare organizations are embracing the promise of generative AI to ease workforce shortages and reduce administrative burdens – but many remain unprepared to implement the technology at scale.
MedTech Innovator is a global accelerator for medical device, digital health and diagnostic companies that evaluates and chooses startups for scalable growth, says CEO Paul Grand.
Blue Shield of California has announced a collaboration with booking platform Zocdoc to allow members to schedule in-network, in-person and virtual care appointments directly on the nonprofit health plan’s online member portal. Blue Shield members can see real-time availability of providers and access more than 1 million hours of bookable appointments available over a 90-day […]
Over the last 20 years, much of drug manufacturing has shifted overseas, according to Johns Hopkins experts. But the work is not going to countries where the cost of labor is less than what it is in the United States.